A clinician's view of voxelotor.
Publication
, Journal Article
Osunkwo, I; Anderson, A; Brown, RC; Shah, N; Estepp, JH
Published in: Br J Haematol
November 2022
Duke Scholars
Published In
Br J Haematol
DOI
EISSN
1365-2141
Publication Date
November 2022
Volume
199
Issue
4
Start / End Page
616 / 618
Location
England
Related Subject Headings
- Pyrazoles
- Pyrazines
- Immunology
- Humans
- Benzaldehydes
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Osunkwo, I., Anderson, A., Brown, R. C., Shah, N., & Estepp, J. H. (2022). A clinician's view of voxelotor. Br J Haematol, 199(4), 616–618. https://doi.org/10.1111/bjh.18455
Osunkwo, Ifeyinwa, Alan Anderson, R Clark Brown, Nirmish Shah, and Jeremie H. Estepp. “A clinician's view of voxelotor.” Br J Haematol 199, no. 4 (November 2022): 616–18. https://doi.org/10.1111/bjh.18455.
Osunkwo I, Anderson A, Brown RC, Shah N, Estepp JH. A clinician's view of voxelotor. Br J Haematol. 2022 Nov;199(4):616–8.
Osunkwo, Ifeyinwa, et al. “A clinician's view of voxelotor.” Br J Haematol, vol. 199, no. 4, Nov. 2022, pp. 616–18. Pubmed, doi:10.1111/bjh.18455.
Osunkwo I, Anderson A, Brown RC, Shah N, Estepp JH. A clinician's view of voxelotor. Br J Haematol. 2022 Nov;199(4):616–618.
Published In
Br J Haematol
DOI
EISSN
1365-2141
Publication Date
November 2022
Volume
199
Issue
4
Start / End Page
616 / 618
Location
England
Related Subject Headings
- Pyrazoles
- Pyrazines
- Immunology
- Humans
- Benzaldehydes
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology